The time for molecular phenotyping of metastatic castrate-resistant prostate cancer is now.

The time for molecular phenotyping of metastatic castrate-resistant prostate cancer is now. Clin Adv Hematol Oncol. 2015 Sep;13(9):580-3 Authors: VanderWeele DJ PMID: 26452188 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research